Tepezza Hearing Loss
In litigation
Mass-tort payouts ($50k+)
mass_tort · pharma
Tepezza hearing loss - MDL alleges the thyroid-eye-disease drug causes permanent hearing damage
Eligibility hint
Were treated with Tepezza infusions and developed hearing loss or tinnitus
Tepezza (teprotumumab), a Horizon Therapeutics infusion drug for thyroid eye disease, is alleged to cause permanent hearing loss and tinnitus that the label failed to adequately warn about. The federal cases are consolidated in an MDL in the Northern District of Illinois. Eligibility centers on having been treated with Tepezza infusions and later developing hearing loss or tinnitus.
Recent signals
Brands:
horizon therapeuticsamgen
Products: tepezzateprotumumabthyroid eye diseasehearing losstinnitus
Products: tepezzateprotumumabthyroid eye diseasehearing losstinnitus
Think this might apply to you?
Take a 30-second audit and we'll match every brand you've used against active settlements.